Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Laryngectomy | 34 | 2024 | 244 | 8.960 |
Why?
|
Surgical Flaps | 47 | 2021 | 1677 | 5.960 |
Why?
|
Head and Neck Neoplasms | 64 | 2024 | 2921 | 5.950 |
Why?
|
Larynx, Artificial | 15 | 2024 | 70 | 5.870 |
Why?
|
Parotid Neoplasms | 12 | 2019 | 157 | 4.610 |
Why?
|
Free Tissue Flaps | 17 | 2024 | 335 | 4.270 |
Why?
|
Laryngeal Neoplasms | 20 | 2024 | 512 | 4.070 |
Why?
|
Carcinoma, Squamous Cell | 47 | 2024 | 4044 | 3.240 |
Why?
|
Trachea | 13 | 2024 | 1085 | 3.210 |
Why?
|
Esophagus | 14 | 2024 | 1037 | 3.080 |
Why?
|
Parotid Gland | 9 | 2023 | 177 | 2.820 |
Why?
|
Prosthesis Implantation | 8 | 2024 | 595 | 2.720 |
Why?
|
Punctures | 13 | 2024 | 373 | 2.340 |
Why?
|
Neck Dissection | 8 | 2021 | 200 | 2.260 |
Why?
|
Tongue Neoplasms | 10 | 2024 | 187 | 1.630 |
Why?
|
Oropharyngeal Neoplasms | 12 | 2022 | 492 | 1.590 |
Why?
|
Pharyngectomy | 9 | 2017 | 45 | 1.560 |
Why?
|
Carcinoma, Adenoid Cystic | 7 | 2022 | 263 | 1.510 |
Why?
|
Carcinoma, Mucoepidermoid | 3 | 2019 | 91 | 1.390 |
Why?
|
Neck | 8 | 2023 | 733 | 1.290 |
Why?
|
Paraganglioma | 3 | 2020 | 143 | 1.290 |
Why?
|
Salivary Gland Neoplasms | 9 | 2022 | 305 | 1.270 |
Why?
|
Postoperative Complications | 34 | 2024 | 15747 | 1.260 |
Why?
|
Hypopharyngeal Neoplasms | 2 | 2024 | 52 | 1.260 |
Why?
|
Mouth Neoplasms | 8 | 2023 | 594 | 1.230 |
Why?
|
Glossectomy | 6 | 2023 | 60 | 1.200 |
Why?
|
Pharyngeal Neoplasms | 5 | 2014 | 113 | 1.150 |
Why?
|
Otorhinolaryngologic Surgical Procedures | 5 | 2021 | 325 | 1.050 |
Why?
|
Facial Nerve | 4 | 2018 | 277 | 1.040 |
Why?
|
Pharyngeal Diseases | 5 | 2019 | 133 | 1.030 |
Why?
|
Prosthesis Failure | 5 | 2020 | 1191 | 1.010 |
Why?
|
Voice Quality | 7 | 2018 | 226 | 1.000 |
Why?
|
Paranasal Sinus Neoplasms | 7 | 2021 | 243 | 0.890 |
Why?
|
Facial Nerve Injuries | 2 | 2017 | 64 | 0.890 |
Why?
|
Esophagoscopy | 4 | 2020 | 398 | 0.890 |
Why?
|
Device Removal | 3 | 2020 | 646 | 0.860 |
Why?
|
Carotid Body Tumor | 2 | 2020 | 32 | 0.860 |
Why?
|
Voice | 2 | 2017 | 268 | 0.850 |
Why?
|
Oral Surgical Procedures | 3 | 2021 | 172 | 0.830 |
Why?
|
Neoplasm Staging | 22 | 2023 | 11206 | 0.830 |
Why?
|
Carcinoma, Acinar Cell | 2 | 2018 | 62 | 0.820 |
Why?
|
Microsurgery | 6 | 2018 | 795 | 0.800 |
Why?
|
Cutaneous Fistula | 5 | 2016 | 80 | 0.800 |
Why?
|
Salvage Therapy | 5 | 2024 | 1272 | 0.780 |
Why?
|
Thyroiditis, Subacute | 1 | 2021 | 11 | 0.770 |
Why?
|
Mandible | 6 | 2015 | 746 | 0.760 |
Why?
|
Deglutition Disorders | 4 | 2023 | 639 | 0.750 |
Why?
|
Facial Paralysis | 3 | 2011 | 346 | 0.740 |
Why?
|
Indians, North American | 3 | 2014 | 354 | 0.740 |
Why?
|
Adenoma, Pleomorphic | 2 | 2012 | 76 | 0.710 |
Why?
|
Retrospective Studies | 65 | 2024 | 81514 | 0.700 |
Why?
|
Neoplasms, Multiple Primary | 3 | 2020 | 587 | 0.690 |
Why?
|
Humans | 207 | 2024 | 765968 | 0.680 |
Why?
|
Blood Transfusion | 2 | 2018 | 1297 | 0.680 |
Why?
|
Speech, Esophageal | 4 | 2018 | 11 | 0.670 |
Why?
|
Male | 138 | 2024 | 363698 | 0.670 |
Why?
|
Temporal Bone | 5 | 2011 | 683 | 0.660 |
Why?
|
Chylothorax | 2 | 2011 | 83 | 0.660 |
Why?
|
Tissue and Organ Harvesting | 3 | 2019 | 373 | 0.650 |
Why?
|
Dissection | 4 | 2019 | 299 | 0.650 |
Why?
|
Voice Disorders | 3 | 2018 | 286 | 0.640 |
Why?
|
Giant Cell Tumor of Bone | 2 | 2011 | 119 | 0.640 |
Why?
|
Middle Aged | 94 | 2024 | 223009 | 0.620 |
Why?
|
Surgical Stomas | 2 | 2020 | 45 | 0.620 |
Why?
|
Sublingual Gland | 1 | 2018 | 11 | 0.610 |
Why?
|
Ranula | 1 | 2018 | 10 | 0.610 |
Why?
|
Papillomavirus Infections | 6 | 2022 | 1640 | 0.610 |
Why?
|
Laryngeal Diseases | 2 | 2020 | 248 | 0.600 |
Why?
|
Parathyroidectomy | 2 | 2011 | 244 | 0.600 |
Why?
|
Treatment Outcome | 45 | 2023 | 65188 | 0.590 |
Why?
|
Masks | 1 | 2020 | 209 | 0.580 |
Why?
|
Cranial Nerve Neoplasms | 2 | 2010 | 131 | 0.580 |
Why?
|
Otolaryngology | 6 | 2020 | 698 | 0.560 |
Why?
|
Tonsillar Neoplasms | 2 | 2016 | 49 | 0.560 |
Why?
|
Aged | 76 | 2021 | 171117 | 0.550 |
Why?
|
Palatal Neoplasms | 1 | 2017 | 37 | 0.550 |
Why?
|
Surgical Wound Infection | 6 | 2021 | 1543 | 0.540 |
Why?
|
Nasopharyngeal Neoplasms | 4 | 2016 | 296 | 0.540 |
Why?
|
Speech, Alaryngeal | 2 | 2015 | 32 | 0.540 |
Why?
|
Fascia | 2 | 2016 | 143 | 0.540 |
Why?
|
Carcinoma | 6 | 2021 | 2312 | 0.540 |
Why?
|
Hair Removal | 1 | 2017 | 41 | 0.530 |
Why?
|
Cysts | 4 | 2011 | 684 | 0.530 |
Why?
|
Intubation, Gastrointestinal | 2 | 2014 | 167 | 0.520 |
Why?
|
Forearm | 6 | 2023 | 427 | 0.520 |
Why?
|
Lymphatic Metastasis | 7 | 2022 | 2887 | 0.520 |
Why?
|
Laryngoscopy | 2 | 2020 | 686 | 0.500 |
Why?
|
Catheters, Indwelling | 1 | 2018 | 438 | 0.500 |
Why?
|
Myiasis | 1 | 2015 | 15 | 0.500 |
Why?
|
Pneumocephalus | 2 | 2008 | 46 | 0.490 |
Why?
|
Cervicoplasty | 1 | 2015 | 8 | 0.490 |
Why?
|
Mandibular Neoplasms | 3 | 2002 | 131 | 0.480 |
Why?
|
Female | 104 | 2024 | 396112 | 0.480 |
Why?
|
Thrombosis | 5 | 2008 | 2949 | 0.480 |
Why?
|
Pectoralis Muscles | 3 | 2020 | 86 | 0.480 |
Why?
|
Pneumonia, Aspiration | 1 | 2015 | 145 | 0.470 |
Why?
|
Radiotherapy, Adjuvant | 8 | 2020 | 1776 | 0.470 |
Why?
|
Suture Techniques | 2 | 2012 | 773 | 0.460 |
Why?
|
Ear Auricle | 1 | 2014 | 31 | 0.460 |
Why?
|
SEER Program | 4 | 2020 | 1446 | 0.460 |
Why?
|
Venous Thrombosis | 3 | 2016 | 1327 | 0.460 |
Why?
|
Anastomosis, Surgical | 8 | 2020 | 990 | 0.460 |
Why?
|
Neoplasm Recurrence, Local | 12 | 2024 | 9373 | 0.460 |
Why?
|
Bronchoscopy | 1 | 2020 | 909 | 0.450 |
Why?
|
Zygoma | 2 | 2011 | 52 | 0.440 |
Why?
|
Ulcer | 1 | 2015 | 201 | 0.440 |
Why?
|
Postoperative Hemorrhage | 2 | 2015 | 413 | 0.440 |
Why?
|
Social Work | 1 | 2015 | 158 | 0.440 |
Why?
|
Prostheses and Implants | 1 | 2020 | 1273 | 0.440 |
Why?
|
Antibiotic Prophylaxis | 3 | 2016 | 644 | 0.430 |
Why?
|
Prosthesis Design | 3 | 2015 | 2105 | 0.430 |
Why?
|
Enteral Nutrition | 3 | 2014 | 803 | 0.430 |
Why?
|
Respiratory Therapy | 1 | 2014 | 124 | 0.420 |
Why?
|
Tracheotomy | 2 | 2018 | 174 | 0.420 |
Why?
|
Graft Survival | 10 | 2015 | 3890 | 0.420 |
Why?
|
Electrosurgery | 2 | 2010 | 53 | 0.420 |
Why?
|
Facial Nerve Diseases | 3 | 2010 | 48 | 0.420 |
Why?
|
Hair | 1 | 2017 | 508 | 0.420 |
Why?
|
Biopsy, Needle | 5 | 2018 | 1628 | 0.410 |
Why?
|
Esophageal Spasm, Diffuse | 2 | 2004 | 3 | 0.410 |
Why?
|
Burnout, Professional | 1 | 2021 | 711 | 0.410 |
Why?
|
Head | 4 | 2023 | 925 | 0.410 |
Why?
|
Hyperbaric Oxygenation | 2 | 2020 | 167 | 0.400 |
Why?
|
Pharynx | 4 | 2008 | 436 | 0.400 |
Why?
|
Pacemaker, Artificial | 1 | 2018 | 827 | 0.390 |
Why?
|
Physicians | 3 | 2021 | 4588 | 0.390 |
Why?
|
Hospital Costs | 1 | 2018 | 956 | 0.390 |
Why?
|
Ultrasonics | 2 | 2010 | 209 | 0.390 |
Why?
|
Fibrinolytic Agents | 3 | 2008 | 2080 | 0.380 |
Why?
|
Skull Base | 1 | 2014 | 293 | 0.380 |
Why?
|
Ticlopidine | 2 | 2007 | 731 | 0.380 |
Why?
|
Parotid Diseases | 2 | 2010 | 50 | 0.380 |
Why?
|
Skin Transplantation | 5 | 2018 | 1098 | 0.380 |
Why?
|
Submandibular Gland Neoplasms | 1 | 2011 | 10 | 0.370 |
Why?
|
Tongue | 3 | 2023 | 405 | 0.370 |
Why?
|
Clavicle | 6 | 2018 | 224 | 0.370 |
Why?
|
Vascular Surgical Procedures | 4 | 2020 | 1485 | 0.360 |
Why?
|
Foreign-Body Migration | 1 | 2013 | 220 | 0.360 |
Why?
|
Sarcoma, Myeloid | 1 | 2011 | 52 | 0.350 |
Why?
|
Otorhinolaryngologic Neoplasms | 1 | 2010 | 26 | 0.350 |
Why?
|
Nose Neoplasms | 3 | 2021 | 249 | 0.350 |
Why?
|
Lymphatic Abnormalities | 1 | 2012 | 134 | 0.340 |
Why?
|
Hypoglossal Nerve Diseases | 1 | 2010 | 8 | 0.340 |
Why?
|
Prosthesis-Related Infections | 1 | 2015 | 496 | 0.340 |
Why?
|
Skull Base Neoplasms | 4 | 2008 | 276 | 0.340 |
Why?
|
Patient Care | 2 | 2020 | 629 | 0.330 |
Why?
|
Dendritic Cell Sarcoma, Follicular | 1 | 2010 | 30 | 0.330 |
Why?
|
Preoperative Care | 3 | 2017 | 2267 | 0.330 |
Why?
|
Laser Therapy | 1 | 2017 | 1108 | 0.330 |
Why?
|
Fluoroscopy | 1 | 2014 | 947 | 0.330 |
Why?
|
Neoplasm Invasiveness | 8 | 2023 | 3602 | 0.330 |
Why?
|
Dilatation | 2 | 2023 | 310 | 0.320 |
Why?
|
Bone Neoplasms | 4 | 2017 | 2567 | 0.320 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2016 | 617 | 0.320 |
Why?
|
Digestive System Surgical Procedures | 1 | 2014 | 580 | 0.320 |
Why?
|
Negative-Pressure Wound Therapy | 1 | 2011 | 156 | 0.320 |
Why?
|
Risk Assessment | 13 | 2022 | 24282 | 0.310 |
Why?
|
Patients | 1 | 2015 | 910 | 0.300 |
Why?
|
Stomach | 1 | 2013 | 699 | 0.300 |
Why?
|
Lipoma | 3 | 2002 | 294 | 0.300 |
Why?
|
Follow-Up Studies | 20 | 2018 | 39193 | 0.300 |
Why?
|
Postoperative Period | 4 | 2018 | 1816 | 0.300 |
Why?
|
Length of Stay | 6 | 2021 | 6485 | 0.300 |
Why?
|
Hamartoma | 1 | 2010 | 233 | 0.290 |
Why?
|
Perioperative Care | 1 | 2016 | 1055 | 0.290 |
Why?
|
Soft Tissue Injuries | 1 | 2009 | 172 | 0.290 |
Why?
|
Face | 3 | 2011 | 1028 | 0.290 |
Why?
|
Tissue Transplantation | 2 | 2006 | 128 | 0.290 |
Why?
|
Combined Modality Therapy | 10 | 2021 | 8529 | 0.280 |
Why?
|
Hirudins | 1 | 2008 | 179 | 0.280 |
Why?
|
Counseling | 1 | 2015 | 1551 | 0.280 |
Why?
|
Survival Rate | 11 | 2021 | 12795 | 0.280 |
Why?
|
Intraoperative Period | 1 | 2008 | 508 | 0.270 |
Why?
|
Adult | 48 | 2024 | 223044 | 0.270 |
Why?
|
Inpatients | 1 | 2018 | 2564 | 0.270 |
Why?
|
Intubation, Intratracheal | 2 | 2018 | 1303 | 0.260 |
Why?
|
Ear Cartilage | 1 | 2006 | 62 | 0.260 |
Why?
|
Aged, 80 and over | 25 | 2021 | 59489 | 0.260 |
Why?
|
Vascular Malformations | 1 | 2012 | 471 | 0.260 |
Why?
|
Surgery, Computer-Assisted | 1 | 2014 | 993 | 0.260 |
Why?
|
Radiotherapy | 4 | 2021 | 1494 | 0.260 |
Why?
|
Clinical Competence | 4 | 2019 | 4863 | 0.250 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3100 | 0.250 |
Why?
|
Otorhinolaryngologic Diseases | 1 | 2006 | 96 | 0.250 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3223 | 0.250 |
Why?
|
Microcirculation | 3 | 2008 | 1280 | 0.250 |
Why?
|
Random Allocation | 5 | 2010 | 2395 | 0.240 |
Why?
|
Hematocrit | 2 | 2018 | 621 | 0.240 |
Why?
|
Ear Canal | 3 | 2007 | 149 | 0.240 |
Why?
|
Diagnosis, Differential | 11 | 2013 | 12976 | 0.240 |
Why?
|
Carotid Arteries | 1 | 2009 | 929 | 0.240 |
Why?
|
Tomography, X-Ray Computed | 14 | 2020 | 20659 | 0.240 |
Why?
|
Mouth Rehabilitation | 1 | 2004 | 10 | 0.240 |
Why?
|
Heparin, Low-Molecular-Weight | 1 | 2007 | 345 | 0.230 |
Why?
|
Salivary Ducts | 1 | 2004 | 25 | 0.230 |
Why?
|
Physicians, Family | 1 | 2006 | 349 | 0.230 |
Why?
|
Wound Healing | 5 | 2020 | 2792 | 0.230 |
Why?
|
Nasal Cavity | 4 | 2021 | 307 | 0.230 |
Why?
|
Platelet Aggregation Inhibitors | 2 | 2007 | 2770 | 0.230 |
Why?
|
Skin Neoplasms | 5 | 2023 | 5849 | 0.220 |
Why?
|
Deglutition | 3 | 2021 | 208 | 0.220 |
Why?
|
Skull | 1 | 2008 | 811 | 0.220 |
Why?
|
Femoral Artery | 2 | 2005 | 811 | 0.220 |
Why?
|
RNA-Binding Protein FUS | 1 | 2024 | 76 | 0.220 |
Why?
|
Prognosis | 14 | 2021 | 29922 | 0.220 |
Why?
|
Bacteria | 1 | 2014 | 2209 | 0.220 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2015 | 4058 | 0.210 |
Why?
|
Attitude of Health Personnel | 2 | 2015 | 3925 | 0.210 |
Why?
|
Radiation Injuries | 2 | 2009 | 1181 | 0.210 |
Why?
|
Osteosarcoma | 2 | 2000 | 909 | 0.210 |
Why?
|
Neoplasms, Second Primary | 1 | 2011 | 1050 | 0.210 |
Why?
|
Peripheral Nerves | 1 | 2006 | 491 | 0.210 |
Why?
|
Rats, Sprague-Dawley | 6 | 2010 | 8102 | 0.210 |
Why?
|
Adenoma | 2 | 2011 | 2152 | 0.200 |
Why?
|
Fibula | 3 | 2024 | 270 | 0.200 |
Why?
|
Veins | 1 | 2007 | 764 | 0.200 |
Why?
|
Neurilemmoma | 1 | 2008 | 522 | 0.200 |
Why?
|
Quality of Life | 8 | 2023 | 13462 | 0.200 |
Why?
|
Platelet Aggregation | 1 | 2005 | 769 | 0.200 |
Why?
|
External Fixators | 1 | 2002 | 99 | 0.200 |
Why?
|
Esophageal Stenosis | 1 | 2023 | 196 | 0.190 |
Why?
|
Rhabdoid Tumor | 1 | 2024 | 209 | 0.190 |
Why?
|
Larynx | 2 | 2018 | 491 | 0.190 |
Why?
|
Salivary Glands, Minor | 1 | 2021 | 26 | 0.190 |
Why?
|
Immunohistochemistry | 8 | 2021 | 11022 | 0.190 |
Why?
|
Magnetic Resonance Imaging | 16 | 2020 | 36532 | 0.190 |
Why?
|
Survival Analysis | 1 | 2014 | 10070 | 0.190 |
Why?
|
Cohort Studies | 10 | 2024 | 41649 | 0.180 |
Why?
|
Ear Neoplasms | 2 | 2014 | 118 | 0.180 |
Why?
|
Papillomaviridae | 3 | 2022 | 1141 | 0.180 |
Why?
|
Nuclear Receptor Coactivators | 1 | 2021 | 62 | 0.180 |
Why?
|
Embolization, Therapeutic | 2 | 2009 | 1403 | 0.180 |
Why?
|
Orbital Diseases | 1 | 2002 | 178 | 0.180 |
Why?
|
Nasal Obstruction | 1 | 2002 | 162 | 0.170 |
Why?
|
Scapula | 2 | 2018 | 174 | 0.170 |
Why?
|
Forecasting | 3 | 2020 | 2936 | 0.170 |
Why?
|
Enoxaparin | 1 | 2003 | 390 | 0.170 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2010 | 1434 | 0.170 |
Why?
|
Speech Therapy | 1 | 2000 | 58 | 0.170 |
Why?
|
Hoarseness | 1 | 2020 | 63 | 0.170 |
Why?
|
Speech Disorders | 1 | 2021 | 178 | 0.170 |
Why?
|
Osteogenesis, Distraction | 2 | 2004 | 232 | 0.170 |
Why?
|
Pharyngeal Muscles | 1 | 2000 | 81 | 0.170 |
Why?
|
Arteries | 2 | 2015 | 1118 | 0.170 |
Why?
|
Spasm | 1 | 2000 | 131 | 0.170 |
Why?
|
Ambulatory Surgical Procedures | 1 | 2024 | 453 | 0.160 |
Why?
|
Sialometaplasia, Necrotizing | 1 | 2019 | 6 | 0.160 |
Why?
|
Cocaine-Related Disorders | 1 | 2002 | 459 | 0.160 |
Why?
|
Bone Transplantation | 1 | 2004 | 920 | 0.160 |
Why?
|
Proto-Oncogene Proteins c-ret | 1 | 2021 | 228 | 0.160 |
Why?
|
Pilot Projects | 8 | 2023 | 8733 | 0.160 |
Why?
|
Rats | 7 | 2010 | 23707 | 0.160 |
Why?
|
Caregivers | 2 | 2004 | 2307 | 0.160 |
Why?
|
Alphapapillomavirus | 1 | 2022 | 219 | 0.160 |
Why?
|
Neoplasm, Residual | 1 | 2024 | 1009 | 0.160 |
Why?
|
Jejunum | 2 | 2015 | 474 | 0.150 |
Why?
|
Shoulder | 2 | 2018 | 297 | 0.150 |
Why?
|
Surgical Instruments | 3 | 2010 | 377 | 0.150 |
Why?
|
Gene Fusion | 1 | 2021 | 357 | 0.150 |
Why?
|
Hospitalization | 1 | 2018 | 10808 | 0.150 |
Why?
|
Esthetics | 2 | 2014 | 326 | 0.150 |
Why?
|
Nose Deformities, Acquired | 1 | 2018 | 44 | 0.150 |
Why?
|
Foreign Bodies | 1 | 2002 | 402 | 0.150 |
Why?
|
Gene Rearrangement | 2 | 2021 | 1144 | 0.150 |
Why?
|
South Dakota | 2 | 2014 | 32 | 0.150 |
Why?
|
Disease-Free Survival | 5 | 2024 | 6832 | 0.150 |
Why?
|
Heparin | 1 | 2005 | 1630 | 0.150 |
Why?
|
Incidence | 6 | 2015 | 21480 | 0.140 |
Why?
|
Nasal Mucosa | 1 | 2021 | 416 | 0.140 |
Why?
|
Air Pollutants, Occupational | 1 | 2020 | 406 | 0.140 |
Why?
|
Humidity | 2 | 2020 | 206 | 0.140 |
Why?
|
Tracheostomy | 3 | 2014 | 429 | 0.140 |
Why?
|
Sound | 1 | 1999 | 257 | 0.140 |
Why?
|
Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 248 | 0.140 |
Why?
|
Analysis of Variance | 3 | 2010 | 6203 | 0.140 |
Why?
|
Lymph Nodes | 3 | 2017 | 3454 | 0.140 |
Why?
|
Models, Biological | 1 | 2013 | 9443 | 0.140 |
Why?
|
Lymphoproliferative Disorders | 2 | 2003 | 526 | 0.140 |
Why?
|
Durapatite | 1 | 2018 | 166 | 0.130 |
Why?
|
Accessory Nerve | 1 | 1996 | 11 | 0.130 |
Why?
|
Anastomotic Leak | 1 | 2018 | 170 | 0.130 |
Why?
|
Biopsy, Fine-Needle | 3 | 2024 | 1133 | 0.130 |
Why?
|
Critical Pathways | 1 | 2020 | 474 | 0.130 |
Why?
|
Skull Neoplasms | 2 | 2007 | 173 | 0.130 |
Why?
|
Hypertrophy | 1 | 2018 | 559 | 0.130 |
Why?
|
Models, Animal | 3 | 2010 | 2120 | 0.130 |
Why?
|
Granulation Tissue | 1 | 2015 | 92 | 0.130 |
Why?
|
Algorithms | 5 | 2021 | 14071 | 0.130 |
Why?
|
Connective Tissue | 1 | 2018 | 425 | 0.130 |
Why?
|
Prosthesis Fitting | 1 | 2015 | 74 | 0.120 |
Why?
|
Constriction, Pathologic | 3 | 2023 | 1105 | 0.120 |
Why?
|
Massachusetts | 4 | 2017 | 8875 | 0.120 |
Why?
|
United States | 9 | 2020 | 72903 | 0.120 |
Why?
|
Estrogen Receptor alpha | 1 | 2019 | 578 | 0.120 |
Why?
|
Meningioma | 1 | 2024 | 1221 | 0.120 |
Why?
|
Povidone-Iodine | 1 | 2015 | 54 | 0.120 |
Why?
|
Diverticulum | 1 | 1996 | 137 | 0.120 |
Why?
|
Urinary Tract Infections | 1 | 2021 | 805 | 0.120 |
Why?
|
Necrosis | 2 | 2015 | 1617 | 0.120 |
Why?
|
Retreatment | 1 | 2017 | 598 | 0.120 |
Why?
|
Injections | 1 | 2018 | 840 | 0.120 |
Why?
|
Attitude to Health | 1 | 2004 | 2020 | 0.120 |
Why?
|
Meningeal Neoplasms | 1 | 2024 | 1252 | 0.120 |
Why?
|
Actinomycosis | 1 | 2014 | 19 | 0.120 |
Why?
|
Reoperation | 6 | 2018 | 4294 | 0.120 |
Why?
|
Clostridium Infections | 1 | 2021 | 564 | 0.120 |
Why?
|
Hyaluronic Acid | 1 | 2018 | 484 | 0.120 |
Why?
|
Bacteremia | 1 | 2021 | 989 | 0.120 |
Why?
|
Tumor Burden | 1 | 2020 | 1885 | 0.110 |
Why?
|
Radiography | 3 | 2010 | 6919 | 0.110 |
Why?
|
Lymphoma | 1 | 2003 | 1897 | 0.110 |
Why?
|
Mastoid | 1 | 2014 | 100 | 0.110 |
Why?
|
Therapeutic Irrigation | 1 | 2015 | 297 | 0.110 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 1 | 2021 | 920 | 0.110 |
Why?
|
Chromates | 1 | 2013 | 22 | 0.110 |
Why?
|
Laryngeal Nerves | 1 | 1994 | 57 | 0.110 |
Why?
|
Caustics | 1 | 2013 | 33 | 0.110 |
Why?
|
Aspirin | 1 | 2005 | 3134 | 0.110 |
Why?
|
Hospitals, Teaching | 1 | 2018 | 1158 | 0.110 |
Why?
|
Sarcoma, Clear Cell | 1 | 2013 | 75 | 0.110 |
Why?
|
Drinking | 1 | 2014 | 196 | 0.100 |
Why?
|
Single-Cell Analysis | 2 | 2022 | 2535 | 0.100 |
Why?
|
Triage | 1 | 2020 | 996 | 0.100 |
Why?
|
Intraoperative Care | 1 | 2017 | 760 | 0.100 |
Why?
|
Respiratory Physiological Phenomena | 1 | 2014 | 190 | 0.100 |
Why?
|
Anti-Infective Agents, Local | 1 | 2015 | 245 | 0.100 |
Why?
|
Family | 1 | 2004 | 3209 | 0.100 |
Why?
|
Infection Control | 1 | 2020 | 983 | 0.100 |
Why?
|
Alaska | 1 | 2012 | 68 | 0.100 |
Why?
|
Burns, Chemical | 1 | 2013 | 123 | 0.100 |
Why?
|
Injections, Subcutaneous | 2 | 2005 | 682 | 0.100 |
Why?
|
Emergency Medical Services | 2 | 2013 | 1938 | 0.100 |
Why?
|
Disease Models, Animal | 2 | 2010 | 18293 | 0.100 |
Why?
|
Risk Factors | 12 | 2020 | 74840 | 0.100 |
Why?
|
Carcinoma, Ductal | 1 | 2012 | 97 | 0.100 |
Why?
|
Hot Temperature | 2 | 2020 | 1433 | 0.100 |
Why?
|
Neuroma, Acoustic | 1 | 2015 | 456 | 0.100 |
Why?
|
Chi-Square Distribution | 2 | 2009 | 3432 | 0.100 |
Why?
|
Neoplasm Metastasis | 3 | 2019 | 4893 | 0.100 |
Why?
|
Accidents, Occupational | 1 | 2013 | 251 | 0.100 |
Why?
|
Leg Injuries | 1 | 2013 | 179 | 0.090 |
Why?
|
Histiocytoma, Benign Fibrous | 1 | 1992 | 66 | 0.090 |
Why?
|
Tacrolimus | 1 | 1995 | 753 | 0.090 |
Why?
|
Chernobyl Nuclear Accident | 1 | 2011 | 15 | 0.090 |
Why?
|
Biopsy | 3 | 2022 | 6763 | 0.090 |
Why?
|
Salivary Gland Diseases | 1 | 2011 | 37 | 0.090 |
Why?
|
Adolescent | 13 | 2018 | 88835 | 0.090 |
Why?
|
Osteoradionecrosis | 1 | 2011 | 51 | 0.090 |
Why?
|
Paranasal Sinus Diseases | 1 | 2012 | 121 | 0.090 |
Why?
|
Ligation | 1 | 2012 | 444 | 0.090 |
Why?
|
Graft Rejection | 2 | 2014 | 4499 | 0.090 |
Why?
|
Femoral Neoplasms | 1 | 2011 | 85 | 0.090 |
Why?
|
Ukraine | 1 | 2011 | 151 | 0.090 |
Why?
|
Educational Measurement | 1 | 2017 | 1260 | 0.090 |
Why?
|
Fistula | 1 | 2012 | 212 | 0.090 |
Why?
|
Oropharynx | 1 | 2011 | 140 | 0.090 |
Why?
|
Steel | 1 | 2010 | 27 | 0.090 |
Why?
|
Pain, Postoperative | 1 | 2020 | 1772 | 0.080 |
Why?
|
Internship and Residency | 3 | 2019 | 5946 | 0.080 |
Why?
|
Chyle | 1 | 2010 | 17 | 0.080 |
Why?
|
Pandemics | 2 | 2020 | 8703 | 0.080 |
Why?
|
Muscular Diseases | 2 | 2000 | 550 | 0.080 |
Why?
|
Young Adult | 9 | 2021 | 59889 | 0.080 |
Why?
|
Pneumonia | 1 | 2021 | 2157 | 0.080 |
Why?
|
Biocompatible Materials | 1 | 2018 | 1682 | 0.080 |
Why?
|
Occupational Exposure | 1 | 2020 | 1805 | 0.080 |
Why?
|
Frozen Sections | 1 | 2010 | 153 | 0.080 |
Why?
|
Anticoagulants | 1 | 2005 | 4862 | 0.080 |
Why?
|
Cranial Nerves | 1 | 2010 | 95 | 0.080 |
Why?
|
Patient Care Team | 1 | 2020 | 2517 | 0.080 |
Why?
|
Cochlea | 1 | 2015 | 847 | 0.080 |
Why?
|
Parathyroid Neoplasms | 1 | 2011 | 244 | 0.080 |
Why?
|
Hemostasis, Surgical | 1 | 2010 | 127 | 0.080 |
Why?
|
Disease Management | 1 | 2020 | 2535 | 0.080 |
Why?
|
Surgery, Plastic | 1 | 1996 | 651 | 0.080 |
Why?
|
Optic Disk Drusen | 1 | 2009 | 38 | 0.080 |
Why?
|
Respiratory Function Tests | 1 | 2014 | 1693 | 0.080 |
Why?
|
Survivors | 1 | 2019 | 2372 | 0.070 |
Why?
|
Poverty | 2 | 2020 | 2714 | 0.070 |
Why?
|
Hematoma | 2 | 2005 | 766 | 0.070 |
Why?
|
Quality of Health Care | 2 | 2016 | 4300 | 0.070 |
Why?
|
Muscle, Skeletal | 2 | 2000 | 4958 | 0.070 |
Why?
|
Academic Medical Centers | 1 | 2018 | 2780 | 0.070 |
Why?
|
Monitoring, Physiologic | 2 | 2013 | 1792 | 0.070 |
Why?
|
Range of Motion, Articular | 1 | 2014 | 1594 | 0.070 |
Why?
|
Occlusive Dressings | 1 | 2007 | 52 | 0.070 |
Why?
|
Speech | 2 | 2021 | 555 | 0.070 |
Why?
|
Neoadjuvant Therapy | 1 | 2018 | 2895 | 0.070 |
Why?
|
Health Care Surveys | 2 | 2016 | 2424 | 0.070 |
Why?
|
Gene Expression | 1 | 2019 | 7584 | 0.070 |
Why?
|
Stents | 1 | 2018 | 3213 | 0.070 |
Why?
|
Splints | 1 | 2007 | 108 | 0.070 |
Why?
|
Thigh | 2 | 1999 | 238 | 0.070 |
Why?
|
Probability | 2 | 2009 | 2475 | 0.070 |
Why?
|
Animals | 10 | 2015 | 168764 | 0.070 |
Why?
|
Health Status Indicators | 2 | 2004 | 966 | 0.060 |
Why?
|
Cystadenocarcinoma | 1 | 2005 | 54 | 0.060 |
Why?
|
Sphenoid Sinus | 2 | 2006 | 100 | 0.060 |
Why?
|
Trismus | 1 | 2005 | 33 | 0.060 |
Why?
|
Manipulation, Orthopedic | 1 | 2005 | 40 | 0.060 |
Why?
|
Accidental Falls | 1 | 2013 | 1078 | 0.060 |
Why?
|
Nose | 2 | 2019 | 519 | 0.060 |
Why?
|
Child | 11 | 2010 | 80564 | 0.060 |
Why?
|
Multivariate Analysis | 1 | 2018 | 12056 | 0.060 |
Why?
|
Education, Medical, Graduate | 1 | 2017 | 2418 | 0.060 |
Why?
|
Health Care Costs | 1 | 2018 | 3242 | 0.060 |
Why?
|
Oncogene Proteins, Fusion | 2 | 2024 | 1608 | 0.060 |
Why?
|
Carcinoma, Basal Cell | 2 | 2007 | 566 | 0.060 |
Why?
|
Tomography, Optical Coherence | 2 | 2009 | 2932 | 0.060 |
Why?
|
Analgesics, Opioid | 1 | 2020 | 3835 | 0.060 |
Why?
|
Angiography | 1 | 2010 | 1581 | 0.060 |
Why?
|
Tissue Survival | 1 | 2004 | 121 | 0.060 |
Why?
|
Mesenchymoma | 1 | 2024 | 50 | 0.060 |
Why?
|
Carcinoma, Merkel Cell | 1 | 2008 | 328 | 0.060 |
Why?
|
Carcinoma, Large Cell | 1 | 2004 | 114 | 0.060 |
Why?
|
Socioeconomic Factors | 2 | 2016 | 7838 | 0.050 |
Why?
|
Diagnostic Techniques, Ophthalmological | 1 | 2006 | 252 | 0.050 |
Why?
|
Logistic Models | 1 | 2018 | 13266 | 0.050 |
Why?
|
Epithelial-Mesenchymal Transition | 2 | 2019 | 752 | 0.050 |
Why?
|
Recombinant Proteins | 2 | 2015 | 6493 | 0.050 |
Why?
|
Positron-Emission Tomography | 2 | 2010 | 6547 | 0.050 |
Why?
|
Nursing Assessment | 1 | 2004 | 107 | 0.050 |
Why?
|
Prospective Studies | 8 | 2021 | 54802 | 0.050 |
Why?
|
Intergenerational Relations | 1 | 2004 | 68 | 0.050 |
Why?
|
Developing Countries | 1 | 2016 | 2911 | 0.050 |
Why?
|
Liver Transplantation | 1 | 1995 | 2412 | 0.050 |
Why?
|
Reed-Sternberg Cells | 1 | 2003 | 78 | 0.050 |
Why?
|
Patient Readmission | 1 | 2017 | 3286 | 0.050 |
Why?
|
Kaplan-Meier Estimate | 1 | 2013 | 6499 | 0.050 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 2 | 2021 | 705 | 0.050 |
Why?
|
Rabbits | 2 | 2006 | 4734 | 0.050 |
Why?
|
Neuromuscular Agents | 1 | 2004 | 148 | 0.050 |
Why?
|
Melanoma | 1 | 2021 | 5719 | 0.050 |
Why?
|
Vascular Patency | 1 | 2005 | 912 | 0.050 |
Why?
|
Health Personnel | 1 | 2016 | 3390 | 0.050 |
Why?
|
Sensitivity and Specificity | 2 | 2022 | 14652 | 0.050 |
Why?
|
Hypophysectomy | 1 | 2001 | 113 | 0.050 |
Why?
|
Sensation | 1 | 2023 | 331 | 0.050 |
Why?
|
Anesthesia, General | 1 | 2009 | 1172 | 0.050 |
Why?
|
Double-Blind Method | 2 | 2006 | 12437 | 0.050 |
Why?
|
Mucocele | 1 | 2001 | 51 | 0.050 |
Why?
|
Adenocarcinoma, Mucinous | 1 | 2005 | 521 | 0.050 |
Why?
|
Submandibular Gland | 1 | 2001 | 83 | 0.050 |
Why?
|
Self-Assessment | 1 | 2004 | 400 | 0.050 |
Why?
|
Transplantation, Autologous | 1 | 2006 | 2120 | 0.050 |
Why?
|
Salivary Glands | 1 | 2022 | 231 | 0.050 |
Why?
|
Transplantation, Heterotopic | 1 | 2001 | 175 | 0.050 |
Why?
|
Esophagoscopes | 1 | 2001 | 16 | 0.050 |
Why?
|
Time Factors | 3 | 2021 | 40065 | 0.050 |
Why?
|
Gastric Mucosa | 1 | 2004 | 602 | 0.050 |
Why?
|
Weight-Bearing | 1 | 2024 | 529 | 0.050 |
Why?
|
Internet | 1 | 2013 | 3106 | 0.050 |
Why?
|
Ubiquitin Thiolesterase | 1 | 2024 | 456 | 0.040 |
Why?
|
Prevalence | 2 | 2016 | 15842 | 0.040 |
Why?
|
Botulinum Toxins, Type A | 1 | 2004 | 238 | 0.040 |
Why?
|
Health Status Disparities | 1 | 2012 | 1880 | 0.040 |
Why?
|
Incisor | 1 | 2001 | 170 | 0.040 |
Why?
|
Bone Marrow | 1 | 2010 | 2921 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-ets | 1 | 2021 | 312 | 0.040 |
Why?
|
Radius | 1 | 2023 | 440 | 0.040 |
Why?
|
Skin | 1 | 1994 | 4489 | 0.040 |
Why?
|
Ilium | 1 | 2000 | 154 | 0.040 |
Why?
|
Adenoidectomy | 1 | 2001 | 171 | 0.040 |
Why?
|
Granuloma, Foreign-Body | 1 | 2000 | 41 | 0.040 |
Why?
|
Feasibility Studies | 1 | 2011 | 5302 | 0.040 |
Why?
|
Psychoacoustics | 1 | 1999 | 59 | 0.040 |
Why?
|
Osteochondroma | 1 | 1999 | 44 | 0.040 |
Why?
|
Palate, Soft | 1 | 2019 | 100 | 0.040 |
Why?
|
Hypopharynx | 1 | 2019 | 53 | 0.040 |
Why?
|
Dermis | 1 | 2000 | 204 | 0.040 |
Why?
|
Contrast Media | 1 | 2012 | 5329 | 0.040 |
Why?
|
Esophagectomy | 1 | 2003 | 477 | 0.040 |
Why?
|
Cytodiagnosis | 1 | 2022 | 453 | 0.040 |
Why?
|
Hemangiopericytoma | 1 | 1999 | 71 | 0.040 |
Why?
|
Mass Screening | 1 | 2014 | 5446 | 0.040 |
Why?
|
Macular Degeneration | 1 | 2006 | 1014 | 0.040 |
Why?
|
Surgical Wound Dehiscence | 1 | 2000 | 215 | 0.040 |
Why?
|
Chemotherapy, Adjuvant | 2 | 2020 | 3537 | 0.040 |
Why?
|
Neck Injuries | 1 | 2000 | 162 | 0.040 |
Why?
|
Catheter-Related Infections | 1 | 2021 | 279 | 0.040 |
Why?
|
Sclerosing Solutions | 1 | 1998 | 80 | 0.040 |
Why?
|
Professional Autonomy | 1 | 2019 | 172 | 0.040 |
Why?
|
Palate | 1 | 2018 | 126 | 0.040 |
Why?
|
Speech Intelligibility | 1 | 1998 | 80 | 0.040 |
Why?
|
Decompression, Surgical | 1 | 2002 | 603 | 0.040 |
Why?
|
Immunosuppressive Agents | 1 | 2010 | 4209 | 0.040 |
Why?
|
Burkitt Lymphoma | 1 | 2000 | 338 | 0.040 |
Why?
|
Age Factors | 1 | 2014 | 18380 | 0.040 |
Why?
|
Cross-Sectional Studies | 4 | 2020 | 26318 | 0.040 |
Why?
|
Smoking | 1 | 2014 | 9081 | 0.040 |
Why?
|
Speech Acoustics | 1 | 1998 | 155 | 0.030 |
Why?
|
Elasticity | 1 | 1999 | 652 | 0.030 |
Why?
|
Sclerotherapy | 1 | 1998 | 184 | 0.030 |
Why?
|
Cerebrospinal Fluid | 1 | 2000 | 539 | 0.030 |
Why?
|
Oncogenes | 1 | 2022 | 1235 | 0.030 |
Why?
|
Clindamycin | 1 | 2016 | 138 | 0.030 |
Why?
|
Doxycycline | 1 | 1998 | 349 | 0.030 |
Why?
|
Arnold-Chiari Malformation | 1 | 1997 | 158 | 0.030 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2003 | 1376 | 0.030 |
Why?
|
Pressure | 1 | 1999 | 1168 | 0.030 |
Why?
|
Patient Selection | 2 | 2000 | 4255 | 0.030 |
Why?
|
Specialization | 1 | 2020 | 777 | 0.030 |
Why?
|
Hodgkin Disease | 1 | 2003 | 1383 | 0.030 |
Why?
|
Equipment Design | 2 | 2001 | 3481 | 0.030 |
Why?
|
Craniocerebral Trauma | 1 | 2000 | 494 | 0.030 |
Why?
|
Retina | 1 | 2006 | 2657 | 0.030 |
Why?
|
Audiometry, Pure-Tone | 1 | 2015 | 210 | 0.030 |
Why?
|
Cadaver | 1 | 2019 | 1359 | 0.030 |
Why?
|
Pakistan | 1 | 2016 | 300 | 0.030 |
Why?
|
DNA, Viral | 1 | 2022 | 2199 | 0.030 |
Why?
|
Sequence Analysis, RNA | 1 | 2022 | 2034 | 0.030 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2022 | 1624 | 0.030 |
Why?
|
Speech Production Measurement | 1 | 1994 | 100 | 0.030 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2020 | 1106 | 0.030 |
Why?
|
Immunoglobulin Light Chains | 1 | 1995 | 290 | 0.030 |
Why?
|
Vocal Cord Paralysis | 1 | 1997 | 275 | 0.030 |
Why?
|
Hepatocyte Growth Factor | 1 | 2015 | 268 | 0.030 |
Why?
|
Kinetics | 1 | 2022 | 6274 | 0.030 |
Why?
|
Neurosurgery | 1 | 2020 | 683 | 0.030 |
Why?
|
Activating Transcription Factor 1 | 1 | 2013 | 27 | 0.030 |
Why?
|
Electroplating | 1 | 2013 | 7 | 0.030 |
Why?
|
Tumor Suppressor Proteins | 1 | 2024 | 2796 | 0.030 |
Why?
|
Case-Control Studies | 2 | 2023 | 22223 | 0.030 |
Why?
|
Neutralization Tests | 1 | 2015 | 735 | 0.030 |
Why?
|
Bangladesh | 1 | 2016 | 745 | 0.030 |
Why?
|
Cleft Palate | 1 | 2019 | 591 | 0.030 |
Why?
|
Neurites | 1 | 2015 | 389 | 0.030 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 2015 | 594 | 0.030 |
Why?
|
Communicable Disease Control | 1 | 2020 | 856 | 0.030 |
Why?
|
Ligands | 1 | 2020 | 3273 | 0.030 |
Why?
|
Carcinoma, Papillary | 1 | 1998 | 788 | 0.030 |
Why?
|
Electroencephalography | 1 | 2009 | 6273 | 0.030 |
Why?
|
S100 Proteins | 1 | 2013 | 217 | 0.030 |
Why?
|
Hair Cells, Auditory | 1 | 2015 | 383 | 0.030 |
Why?
|
Burn Units | 1 | 2013 | 143 | 0.030 |
Why?
|
Calmodulin-Binding Proteins | 1 | 2013 | 237 | 0.020 |
Why?
|
Child, Preschool | 3 | 2005 | 42500 | 0.020 |
Why?
|
Neuroectodermal Tumors | 1 | 2012 | 23 | 0.020 |
Why?
|
RNA-Binding Protein EWS | 1 | 2013 | 212 | 0.020 |
Why?
|
Touch | 1 | 1994 | 309 | 0.020 |
Why?
|
Demography | 1 | 2015 | 1641 | 0.020 |
Why?
|
Health Services | 1 | 2016 | 756 | 0.020 |
Why?
|
Health Status | 1 | 2004 | 4080 | 0.020 |
Why?
|
Predictive Value of Tests | 3 | 2021 | 15398 | 0.020 |
Why?
|
Etoposide | 1 | 2012 | 636 | 0.020 |
Why?
|
Repressor Proteins | 1 | 2021 | 2968 | 0.020 |
Why?
|
Cough | 1 | 1994 | 597 | 0.020 |
Why?
|
Hearing Loss, Sensorineural | 1 | 2015 | 781 | 0.020 |
Why?
|
Gene Expression Profiling | 2 | 2017 | 9525 | 0.020 |
Why?
|
India | 1 | 2016 | 2334 | 0.020 |
Why?
|
Paranasal Sinuses | 1 | 2012 | 267 | 0.020 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2012 | 11868 | 0.020 |
Why?
|
Mental Health | 1 | 2004 | 3278 | 0.020 |
Why?
|
Practice Guidelines as Topic | 1 | 2006 | 7425 | 0.020 |
Why?
|
Radiotherapy Dosage | 2 | 2006 | 2865 | 0.020 |
Why?
|
Ambulatory Care | 1 | 2000 | 2778 | 0.020 |
Why?
|
Infant | 3 | 2002 | 36386 | 0.020 |
Why?
|
Sarcoma | 2 | 2012 | 1802 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2021 | 3655 | 0.020 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2012 | 904 | 0.020 |
Why?
|
Survival | 1 | 2008 | 160 | 0.020 |
Why?
|
Focus Groups | 1 | 2014 | 1459 | 0.020 |
Why?
|
Health Services Needs and Demand | 1 | 2016 | 1406 | 0.020 |
Why?
|
Patient Discharge | 1 | 2021 | 3461 | 0.020 |
Why?
|
Gene Amplification | 1 | 2012 | 1091 | 0.020 |
Why?
|
Esthesioneuroblastoma, Olfactory | 1 | 2008 | 57 | 0.020 |
Why?
|
Renal Insufficiency | 1 | 2013 | 804 | 0.020 |
Why?
|
Staphylococcal Infections | 1 | 2016 | 1393 | 0.020 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2013 | 2505 | 0.020 |
Why?
|
Cost-Benefit Analysis | 1 | 2020 | 5526 | 0.020 |
Why?
|
Reaction Time | 1 | 1994 | 2086 | 0.020 |
Why?
|
Ear, External | 1 | 2007 | 164 | 0.020 |
Why?
|
Visual Field Tests | 1 | 2009 | 415 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2020 | 4642 | 0.020 |
Why?
|
Neutrons | 1 | 2006 | 78 | 0.020 |
Why?
|
Societies, Medical | 1 | 2018 | 3956 | 0.020 |
Why?
|
Eye Enucleation | 1 | 2006 | 128 | 0.020 |
Why?
|
Cranial Fossa, Posterior | 1 | 2006 | 134 | 0.020 |
Why?
|
Amifostine | 1 | 2005 | 39 | 0.020 |
Why?
|
Anesthetics, Intravenous | 1 | 2009 | 397 | 0.020 |
Why?
|
Cisplatin | 1 | 2012 | 1658 | 0.020 |
Why?
|
Cavernous Sinus | 1 | 2006 | 119 | 0.020 |
Why?
|
Databases, Factual | 1 | 2021 | 8067 | 0.020 |
Why?
|
Ear, Middle | 1 | 2007 | 341 | 0.020 |
Why?
|
Quality Assurance, Health Care | 1 | 2015 | 2172 | 0.010 |
Why?
|
Thyroid Neoplasms | 1 | 1998 | 2371 | 0.010 |
Why?
|
Guideline Adherence | 1 | 2015 | 2243 | 0.010 |
Why?
|
RNA-Binding Proteins | 1 | 2013 | 1874 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2019 | 12509 | 0.010 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2015 | 3513 | 0.010 |
Why?
|
Carbon Dioxide | 1 | 2009 | 1137 | 0.010 |
Why?
|
Tumor Microenvironment | 1 | 2017 | 3946 | 0.010 |
Why?
|
Registries | 1 | 2020 | 8297 | 0.010 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2015 | 4348 | 0.010 |
Why?
|
Acoustic Stimulation | 1 | 2009 | 1255 | 0.010 |
Why?
|
Apoptosis | 1 | 2020 | 9514 | 0.010 |
Why?
|
Quality Improvement | 1 | 2019 | 3853 | 0.010 |
Why?
|
Orbital Neoplasms | 1 | 2006 | 223 | 0.010 |
Why?
|
Adenocarcinoma | 3 | 2008 | 6364 | 0.010 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2012 | 2878 | 0.010 |
Why?
|
Propofol | 1 | 2009 | 606 | 0.010 |
Why?
|
Carbon | 1 | 2006 | 677 | 0.010 |
Why?
|
Maximum Tolerated Dose | 1 | 2005 | 898 | 0.010 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2012 | 2054 | 0.010 |
Why?
|
Visual Fields | 1 | 2009 | 1063 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2017 | 18973 | 0.010 |
Why?
|
Receptor, erbB-2 | 1 | 2012 | 2593 | 0.010 |
Why?
|
Vision Disorders | 1 | 2009 | 1087 | 0.010 |
Why?
|
Protons | 1 | 2006 | 1073 | 0.010 |
Why?
|
Groin | 1 | 2001 | 106 | 0.010 |
Why?
|
Breast Neoplasms | 2 | 2021 | 21056 | 0.010 |
Why?
|
Eustachian Tube | 1 | 2001 | 99 | 0.010 |
Why?
|
Genotype | 1 | 2012 | 13024 | 0.010 |
Why?
|
Paclitaxel | 1 | 2005 | 1728 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2016 | 7478 | 0.010 |
Why?
|
Bone Plates | 1 | 1999 | 469 | 0.010 |
Why?
|
Protein Kinase Inhibitors | 1 | 2012 | 5696 | 0.010 |
Why?
|
Signal Transduction | 1 | 2019 | 23601 | 0.010 |
Why?
|
Bone Screws | 1 | 1999 | 532 | 0.010 |
Why?
|
Imaging, Three-Dimensional | 1 | 2009 | 4034 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2013 | 15880 | 0.010 |
Why?
|
Osteotomy | 1 | 1999 | 833 | 0.010 |
Why?
|
Fatal Outcome | 1 | 1998 | 1831 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2009 | 8923 | 0.010 |
Why?
|
HIV Infections | 1 | 1998 | 17533 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2012 | 13648 | 0.010 |
Why?
|
Mice | 1 | 2015 | 81819 | 0.000 |
Why?
|
Wounds and Injuries | 1 | 2001 | 2511 | 0.000 |
Why?
|
Mutation | 1 | 2012 | 30198 | 0.000 |
Why?
|
Tissue Donors | 1 | 1998 | 2395 | 0.000 |
Why?
|
Brain | 1 | 2009 | 27171 | 0.000 |
Why?
|